NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues. (Q54572195)

1 June 2018

title

NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues. (English)

1 reference

1 June 2018

0 references

Issaka Yougbare

1

1 reference

1 June 2018

Caroline Morin

2

1 reference

1 June 2018

Farid Yannick Senouvo

3

1 reference

1 June 2018

Chantal Sirois

4

1 reference

1 June 2018

Roula Albadine

5

1 reference

1 June 2018

Claire Lugnier

6

1 reference

1 June 2018

Eric Rousseau

7

1 reference

1 June 2018

publication date

22 July 2011

1 reference

1 June 2018

American Journal of Physiology - Lung Cellular and Molecular Physiology

published in

1 reference

1 June 2018

volume

301

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

L441-50

1 reference

1 June 2018

The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Cyclic nucleotide phosphodiesterase in human bronchial epithelial cells: characterization of isoenzymes and functional effects of PDE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Phosphodiesterase inhibitors in airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Effect of short-term organoid culture on the pharmaco-mechanical properties of rat extra- and intrapulmonary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Keynote review: phosphodiesterase-4 as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Differential expression of cyclic nucleotide phosphodiesterases 4 in developing rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

PDE4D plays a critical role in the control of airway smooth muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Organ-cultured airway explants: a new model of airway hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

CPI-17 silencing-reduced responsiveness in control and TNF-alpha-treated human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Monoammonium glycyrrhizinate inhibited the inflammation of LPS-induced acute lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Maternal exposure to secondhand cigarette smoke primes the lung for induction of phosphodiesterase-4D5 isozyme and exacerbated Th2 responses: rolipram attenuates the airway hyperreactivity and muscarinic receptor expression but not lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

PDE4 inhibitors: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

The role of PDE4 in pulmonary inflammation and goblet cell hyperplasia in allergic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Zl-n-91, a selective phosphodiesterase 4 inhibitor, suppresses inflammatory response in a COPD-like rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

Targeting lung inflammation: novel therapies for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00407.2010

10.1152/AJPLUNG.00407.2010

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018